126 related articles for article (PubMed ID: 3281910)
1. Mitogenic activities of synthetic Escherichia coli lipid A and a synthetic partial structure (tripalmitoyl pentapeptide) of E. coli lipoprotein.
Brade L; Bessler WG; Brade H
Infect Immun; 1988 May; 56(5):1382-4. PubMed ID: 3281910
[TBL] [Abstract][Full Text] [Related]
2. Synthetic analogues of the N-terminal lipid part of bacterial lipoprotein are B-lymphocyte mitogens in vitro and in vivo.
Johnson RB; Köhl S; Wiesmüller K; Jung G; Bessler WG
Immunobiology; 1983 Jul; 165(1):27-35. PubMed ID: 6350164
[TBL] [Abstract][Full Text] [Related]
3. Interaction of mitogenic bacterial lipoprotein and a synthetic analogue with mouse lymphocytes. Isolation and characterization of binding proteins.
Biesert L; Scheuer W; Bessler WG
Eur J Biochem; 1987 Feb; 162(3):651-7. PubMed ID: 3549292
[TBL] [Abstract][Full Text] [Related]
4. A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant.
Lex A; Wiesmüller KH; Jung G; Bessler WG
J Immunol; 1986 Oct; 137(8):2676-81. PubMed ID: 3531339
[TBL] [Abstract][Full Text] [Related]
5. Binding of a synthetic analogue of mitogenic bacterial lipoprotein to murine major histocompatibility complex (MHC) gene products.
Scheuer WV; Biesert L; Bessler WG
Biol Chem Hoppe Seyler; 1986 Oct; 367(10):1085-94. PubMed ID: 3491614
[TBL] [Abstract][Full Text] [Related]
6. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes.
Bessler WG; Cox M; Lex A; Suhr B; Wiesmüller KH; Jung G
J Immunol; 1985 Sep; 135(3):1900-5. PubMed ID: 3874908
[TBL] [Abstract][Full Text] [Related]
7. LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS.
Williamson SI; Wannemuehler MJ; Jirillo E; Pritchard DG; Michalek SM; McGhee JR
J Immunol; 1984 Nov; 133(5):2294-300. PubMed ID: 6332842
[TBL] [Abstract][Full Text] [Related]
8. Biological activity of the Escherichia coli lipoprotein: detection of novel lymphocyte activating peptide segments of the molecule and their conformational characterization.
Loleit M; Deres K; Wiesmüller KH; Jung G; Eckert M; Bessler WG
Biol Chem Hoppe Seyler; 1994 Jun; 375(6):407-12. PubMed ID: 7980873
[TBL] [Abstract][Full Text] [Related]
9. Isolation of a lipid A bound polypeptide responsible for "LPS-initiated" mitogenesis of C3H/HeJ spleen cells.
Morrison DC; Betz SJ; Jacobs DM
J Exp Med; 1976 Sep; 144(3):840-6. PubMed ID: 182900
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of the mitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escherichia coli lipoprotein.
Wiesmüller KH; Bessler W; Jung G
Hoppe Seylers Z Physiol Chem; 1983 May; 364(5):593-606. PubMed ID: 6347861
[TBL] [Abstract][Full Text] [Related]
11. Comparison of biologic activities of synthetic lipopentapeptide analogs of bacterial lipoprotein in mice.
Shimizu T; Ohtsuka Y; Yanagihara Y; Kurimura M; Takemoto M; Achiwa K
Mol Biother; 1991 Mar; 3(1):46-50. PubMed ID: 2069759
[TBL] [Abstract][Full Text] [Related]
12. Polyclonal B-cell activation by a synthetic analogue of bacterial lipoprotein is functionally different from activation by bacterial lipopolysaccharide.
Kleine B; Sprenger R; Martinez-Alonso C; Bessler WG
Immunology; 1987 May; 61(1):29-34. PubMed ID: 3495485
[TBL] [Abstract][Full Text] [Related]
13. Immunologic properties of bacterial lipopolysaccharide (LPS). II. The unresponsiveness of C3H/HeJ Mouse spleen cells to LPS-induced mitogenesis is dependent on the method used to extract LPS.
Skidmore BJ; Morrison DC; Chiller JM; Weigle WO
J Exp Med; 1975 Dec; 142(6):1488-1508. PubMed ID: 1104747
[TBL] [Abstract][Full Text] [Related]
14. Resemblance of blast responses of C3H/HeJ mouse and rabbit spleen lymphocytes to B-cell mitogenic components of E. coli cell walls.
Bona C
Immunol Commun; 1976; 5(1-2):97-107. PubMed ID: 780269
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of splenocytes in C3H/HeJ mice with Porphyromonas gingivalis lipid A in comparison with enterobacterial lipid A.
Ogawa T; Shimauchi H; Uchida H; Mori Y
Immunobiology; 1996; 196(4):399-414. PubMed ID: 9061380
[TBL] [Abstract][Full Text] [Related]
16. Immunostimulation of C3H/HeJ lymphoid cells by R-chemotype lipopolysaccharide preparations.
Flebbe L; Vukajlovich SW; Morrison DC
J Immunol; 1989 Jan; 142(2):642-52. PubMed ID: 2642946
[TBL] [Abstract][Full Text] [Related]
17. Synthetic lipopeptide immunomodulators derived from bacterial lipoprotein: tools for the standardization of in vitro assays.
Bessler WG
Dev Biol Stand; 1992; 77():49-56. PubMed ID: 1426672
[TBL] [Abstract][Full Text] [Related]
18. The mitogenic principle of Escherichia coli lipoprotein: B-lymphocyte mitogenicity of the synthetic analogue palmitoyl-tetrapeptide (Pam-Ser-Ser-Asn-Ala).
Bessler WG; Cox M; Wiesmüller KH; Jung G
Biochem Biophys Res Commun; 1984 May; 121(1):55-61. PubMed ID: 6375670
[TBL] [Abstract][Full Text] [Related]
19. Biological activities of Brucella abortus lipopolysaccharides.
Moreno E; Berman DT; Boettcher LA
Infect Immun; 1981 Jan; 31(1):362-70. PubMed ID: 6783538
[TBL] [Abstract][Full Text] [Related]
20. Biological properties of the native and synthetic lipid A of Porphyromonas gingivalis lipopolysaccharide.
Kumada H; Haishima Y; Watanabe K; Hasegawa C; Tsuchiya T; Tanamoto K; Umemoto T
Oral Microbiol Immunol; 2008 Feb; 23(1):60-9. PubMed ID: 18173800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
